Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Haleos Labs's Enterprise Value is ₹6,221 Mil.
Haleos Labs's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹316 Mil. Therefore, Haleos Labs's EV-to-EBIT ratio for today is 19.66.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Haleos Labs's Enterprise Value is ₹6,221 Mil.
Haleos Labs's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹471 Mil. Therefore, Haleos Labs's EV-to-EBITDA ratio for today is 13.21.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Haleos Labs's Enterprise Value is ₹6,221 Mil.
Haleos Labs's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ₹3,338 Mil. Therefore, Haleos Labs's EV-to-Revenue ratio for today is 1.86.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Haleos Labs's Enterprise Value is ₹6,221 Mil.
Haleos Labs's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil. Therefore, Haleos Labs's EV-to-FCF ratio for today is .
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Haleos Labs (NSE:HALEOSLABS) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Haleos Labs's current Enterprise Value is ₹6,221 Mil.
Haleos Labs's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹316 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Haleos Labs's current Enterprise Value is ₹6,221 Mil.
Haleos Labs's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹471 Mil.
Haleos Labs's current Enterprise Value is ₹6,221 Mil.
Haleos Labs's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,338 Mil.
Haleos Labs's current Enterprise Value is ₹6,221 Mil.
Haleos Labs's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.
Haleos Labs's current Enterprise Value is ₹6,221 Mil.
Haleos Labs's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haleos Labs Enterprise Value Related Terms
Haleos Labs Enterprise Value Historical Data
* Premium members only.
The historical data trend for Haleos Labs's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:HALEOSLABS vs VRTX, REGN, ALNY: Enterprise Value Comparison
For the Biotechnology subindustry, Haleos Labs's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haleos Labs Enterprise Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Haleos Labs's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Haleos Labs's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Haleos Labs's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haleos Labs (NSE:HALEOSLABS) has a Enterprise Value of ₹6,221 Mil as of Jul. 12, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Haleos Labs and its competitors.
Is Haleos Labs' Enterprise Value too high?
Haleos Labs' current Enterprise Value is ₹6,221 Mil. Overall, Haleos Labs has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Haleos Labs' Enterprise Value compare to VRTX and REGN?
Haleos Labs' Enterprise Value of ₹6,221 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Biotechnology company?
A good Enterprise Value depends on the Biotechnology industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Haleos Labs and its competitors. Haleos Labs's current Enterprise Value is ₹6,221 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haleos Labs stock overvalued right now?
Based on GuruFocus' analysis, Haleos Labs (NSE:HALEOSLABS) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1,124.05, compared to a current price of ₹1,596.60 — trading 42% above its estimated fair value. The current Enterprise Value is ₹6,221 Mil. Haleos Labs' overall GF Score™ is 76/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Haleos Labs (NSE:HALEOSLABS), the current Enterprise Value is ₹6,221 Mil as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Haleos Labs (NSE:HALEOSLABS) Overvalued in 2026?
Based on GuruFocus' analysis, Haleos Labs stock appears to be overvalued.
The current stock price of ₹1,596.60 is trading 42% above its estimated GF Value™ of ₹1,124.05.
GuruFocus considers Haleos Labs to be Significantly Overvalued.
Key valuation signals for NSE:HALEOSLABS:
Enterprise Value: ₹6,221 Mil
GF Value™: ₹1,124.05 vs. price of ₹1,596.60 (42% above fair value)
No single metric tells the full story. See the NSE:HALEOSLABS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Haleos Labs Ltd is engaged in the Business of manufacturing Active Pharmaceutical Ingredients (APIs) and its intermediates and sells its products in India as well as exports. The group sells its products in India and also exports it to other countries. Some of its API products are used in therapy as an Antiulcer, Antifungal, Anti Obesity, Anesthesia, and others. The company has manufacturing facilities at Kazipally and Jeedimetla and its Research and Development center at Sanatnagar in Hyderabad.
76GF Score
Get the complete analysis for NSE:HALEOSLABS
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:HALEOSLABS has been successfully added to your 
